CD44-induced epithelial-mesenchymal transition (EMT), however, is strongly correlated with cancer metastasis and is regulated by TGF-β1, and the anti-tumor effect could inhibit the expression of both CD44 and TGF-β [75]. The gene discussed is TGFB1; the disease is neoplasm.